Abbott Diagnostics Technologies Afinion HbA1c - HSA Registration DE0019523
Access comprehensive regulatory information for Abbott Diagnostics Technologies Afinion HbA1c in the Singapore medical device market through Pure Global AI's free database. This CLASS B IVD medical device is registered under HSA registration number DE0019523 and owned by Abbott Diagnostics Technologies AS. The device was registered on August 22, 2017.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
Alere Afinion™ HbA1c is an in vitro diagnostic test for quantitative determination of glycated hemoglobin (hemoglobin A1c, HbA1c) in human whole blood. The measure of HbA1c is recommended as a marker of long-term metabolic control in persons with diabetes mellitus. This test can be used as an aid in the diagnosis of diabetes and as an aid in identifying patients who may be at risk of developing diabetes.